Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Bringing the Clinical Trial to the Patient in Preclinical Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks


Clinical trial teams now need testing solutions that are effective and equivalent when deployed outside of the clinical site.

With the first demonstration that anti-amyloid therapies can slow amyloid accumulation and reduce clinical disease progression in symptomatic Alzheimer’s disease, there is increasing focus on the extent to which disease modifying therapies, applied very early in AD, may delay symptom onset itself.

With focus turning to clinical trials in the preclinical stage of Alzheimer’s disease, clinical trial design is faced with new challenges and new opportunities. The requirement for identifying abnormal Alzheimer’s disease biology in cognitively unimpaired adults is being made easier with the industrialization of blood-based biomarkers for amyloid and tau. In the same vein, engaging, screening, recruiting and even assessing clinical status in cognitively unimpaired adults is facilitated through use of remote clinical assessment.

Clinical trial teams now need testing solutions that are effective and equivalent when deployed outside of the clinical site. Utilizing remote testing allows participants to be assessed from the comfort of their home, typically reducing the number of site visits, and supporting faster and more diverse recruitment which allows studies to be extended to include samples from underrepresented populations.

Cogstate technologies have been used in remote contexts in clinical trials and research for decades. This experience provides the basis for their current application in Phase III registration of trials of disease-modifying therapies in preclinical Alzheimer’s disease.

This webinar will consider the types of remote cognitive assessments that can be applied in clinical trials, aspects of trial design to which they apply and the methodological issues that require consideration when cognitive assessments are conducted remotely. The featured speakers conclude with consideration for the potential opportunities afforded by use of remote cognitive assessment in preclinical Alzheimer’s disease.

Join experts from Cogstate, Paul Maruff, PhD, Chief Innovation Officer; and Chris Edgar, PhD, Chief Science Officer, for the live webinar on Thursday, December 15, 2022, at 1pm EST (10am PST).

For more information, or to register for this event, visit Bringing the Clinical Trial to the Patient in Preclinical Alzheimer’s Disease.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

NGS Solutions for FFPE Materials — Maximizing Immuno-Oncology Insights with Challenging Clinical Samples, Upcoming Webinar Hosted by Xtalks


The physical and chemical modifications following formalin fixation can pose difficulties — such as DNA degradation, cross-linking and fragmentation — for NGS processes.

Formalin-fixed biological specimens are an invaluable resource for the extraction of DNA, RNA and protein. By providing information on single-gene mutations through next-generation sequencing (NGS) processes, FFPE (Formalin-Fixed Paraffin-Embedded) samples enable precision medicine and cancer genetics studies. In addition, FFPE tissues are more readily available and easier to handle in clinical practice than fresh frozen tissues. However, the physical and chemical modifications following formalin fixation can pose difficulties — such as DNA degradation, cross-linking and fragmentation — for NGS processes.

In this webinar, the featured speaker shares insights into FFPE fixation conditions, quality metrics that are most predictive of success, and how to leverage assay design when working with these precious specimens. Highlights of the Personalis clinical laboratory experience in providing robust genomic solutions for clinical research and diagnostic applications from both limited and challenging studies will be presented.

Register for this webinar to gain insights into maximizing immuno-oncology insights for challenging clinical samples with NGS solutions.

Join Erin N. Newburn, MS, PhD, Director, Field Applications Scientist, Personalis, Inc., for the live webinar on Thursday, December 15, 2022, at 12pm EST (9am PST).

For more information, or to register for this event, visit NGS Solutions for FFPE Materials — Maximizing Immuno-Oncology Insights with Challenging Clinical Samples.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

SporTherapy Physical Therapy & Sports Medicine Opens New Clinic in Mansfield


News Image

“This clinic is a great opportunity for us to meet the needs of our patients and offer excellent customer service/care to the Mansfield community. I look forward to helping the community work to achieve their optimal level of function.” – Sydnie Darden, Mansfield Clinic Director

SporTherapy Physical Therapy & Sports Medicine (SporTherapy) is pleased to announce their newest clinic has opened today in Mansfield, TX. Located at 167 Regency Parkway, Unit 105, the clinic is SporTherapy’s 11th location.

Sydnie Darden, PT, DPT, will serve as the Mansfield Clinic Director and primary treating physical therapist.

SporTherapy specializes in providing exceptional physical therapy through a combination of evidence-based practice, care excellence, and clinical excellence. Services offered from the Mansfield clinic will include general orthopedic services across all age groups, sports injury therapy, balance, and vestibular therapy, TMJ therapy, and treatment for gait disorders, stroke, Parkinson’s, and MS. In addition, they also offer assistive device fittings and therapeutic taping.

“I am excited to be opening this new location in Mansfield, and to be a part of the SporTherapy team,” says Darden. “This clinic is a great opportunity for us to meet the needs of our patients and offer excellent customer service/care to the Mansfield community. I look forward to helping the community work to achieve their optimal level of function.”

For more information about the new Mansfield clinic and a full list of SporTherapy’s services and offerings, please visit https://sportherapy.com/. To book an appointment with Sydnie, please call 682-341-0076.

###

About SporTherapy

SporTherapy (ST) is a Texas-based, private physical therapy practice group. As a proud member of the Confluent Health family, ST positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit sportherapy.com, or find them on Facebook at @sportherapypt.

Share article on social media or email:

Healthie Co-Founder and CTO, Cavan Klinsky, Named to Forbes 30 Under 30


News Image

“We’ve all had a subpar healthcare experience, and our ability to use technology to decrease the frequency of those experiences, facilitate more collaborative care, and enable access to your care team before you’re ill is what keeps us pushing forward.”

Cavan Klinsky, co-founder and CTO of healthcare technology provider, Healthie, was recently named to the annual Forbes 30 Under 30 List for the Class of 2023 in the Healthcare vertical. The list recognizes young disruptors across 20 categories who are changing the face of their respective industries globally. Cavan was selected from a pool of tens of thousands of entrants and was honored for his role in advancing healthcare technology and providing better patient outcomes by way of Healthie’s digital health platform.

“Healthie is all about making the patient experience and patient outcomes better,” said Klinsky. “We’ve all had a subpar healthcare experience, and our ability to use technology to decrease the frequency of those experiences, facilitate more collaborative care, and enable access to your care team before you’re ill is what keeps us pushing forward. We truly believe we can change the future of healthcare with Healthie, and to be placed in this Forbes 30 Under 30 class with other innovators also trying to change the space is a real honor.”

Klinsky founded Healthie in 2016 after meeting co-founder Erica Jain at The University of Pennsylvania. Inspired by the idea of a better healthcare experience powered by technology and bolstered by his experience with his own chronic health condition, Klinsky left college to focus on Healthie full-time, teaching himself to code and building the software from the ground up. Today, Healthie has the most comprehensive, feature-rich, and flexible options for delivering and scaling a digital, virtual-first health platform. Sitting at the center of provider and customer interaction, Healthie houses business, operational, financial, and health information for customers and powers a better experience for thousands of patients daily through key partners.

“I’m motivated by the range and type of companies we support, from weight loss and chronic pain to addiction treatment, behavioral health, and most poignantly, cardiac rehab,” Klinsky continued. “Healthie enables these companies to stay laser-focused on delivering amazing care to their patients, and I’m grateful that I’ve been lucky enough to contribute to that mission.”

To compile the list, Forbes collaborated with an expert panel of judges, including Joe Jonas, singer, songwriter, and actor; Aimee Song, designer, and fashion blogger; Bobbi Brown, makeup artist, author, and founder of Bobbi Brown Cosmetics; and Sid Sijbrandij, co-founder and CEO of business software firm GitLab. Forbes’ Under 30 Class of 2023 features honorees in multiple categories, including: art and style, media, entertainment, social media, science, sports, healthcare, energy, enterprise tech, consumer tech, music, finance, food and drink, social impact, manufacturing and industry, venture capital, marketing and advertising, retail and e-commerce, games, and education.

For more information on Cavan Klinsky, please click here. For more information on Healthie, visit http://www.gethealthie.com.

ABOUT HEALTHIE

Healthie offers infrastructure for next generation digital health organizations that provide virtual-first care. Healthie’s API-first and fully brandable suite of solutions (Scheduling, EMR, Client Engagement) enables healthcare builders to launch and scale best-in-class experiences for their members. The company also offers a built-in marketplace of business and clinical integrations used by their organizations.

Healthie is HIPAA Compliant and SOC-2 Certified. Healthie’s customers include prominent digital health companies that have raised $2B+ in venture capital and range from 5-person startups to multi-billion-dollar companies. In partnership with Healthie, they care for patients across the full spectrum — from preventative health & wellness to complex chronic care management, for millions of patients. For more information, visit http://www.gethealthie.com

Share article on social media or email:

Guidea invests $500k in FemTech innovation through UX design sponsorship program


While it’s hard to estimate the impact the Femovate program will have on the future, every successful FemTech solution works to close the gap in research and provide insight for further innovation in women’s health.

Guidea, an award-winning UX design agency and partner to 20 Fortune 100 companies, is investing $500k in FemTech innovation through their UX design sponsorship program Femovate.

Health-related technology for females is decades behind other areas of healthcare. FemTech founders are fighting against massive scientific and clinical data gaps as well as great funding inequalities — all while trying to save or improve the lives of millions of women.

The Femovate program offers women’s health digital innovation startups UX research, design, and mentorship services at little to no cost. Guidea Founder and CEO Theresa Neil, created the program to help FemTech founders quickly create and/or refine their UX to provide a better experience for users and improve traction with investors.

While the program was originally designed to only sponsor three FemTech companies this year, Neil said she was “blown away” by the founders’ vision. This prompted her to expand the program to include 30 of the 100 FemTech applicants — expanding the originally planned $50k investment in women’s health innovation to $500k.

“Women in tech have the power to support innovation in female-centric healthcare. We believe investing in these FemTech founders will have a transformative impact on our world,” said Neil.

Leveraging their extensive experience in MedTech, IoT, wearables, population health insights, digital therapeutics, and healthcare software, Neil says the team at Guidea will provide game-changing support to the FemTech founder community.

“While it’s hard to estimate the impact the Femovate program will have on the future, every successful FemTech innovation works to close the gap in research and provide insight for further innovation in women’s health,” said Neil. “Guidea is proud to help design better health solutions for women and believe this guidance will create ripple effects in the industry, for years to come.”

++ About Theresa Neil, Founder, and CEO of Guidea++

Theresa is a tech visionary recognized by Business Insider as a “Top Designer in Technology”. She is an O’Reilly author as well as the founder of Guidea, a UX design and research consultancy, an Inc 5000 Fastest Growing Private Company

In addition to providing strategic product design for MedTech and HealthTech, Theresa is an angel investor and start-up mentor. She recently launched Femovate, a FemTech acceleration project, offering design, research, and go-to-market mentorship to a select group of entrepreneurs who promise to change women’s healthcare with unique digital offerings.

++ About Guidea ++

Guidea is a women-led UX consultancy with extensive product and design strategy expertise in HealthTech and MedTech. The team is a trusted partner to 20 Fortune 100 companies and has launched almost 300 products and services to date. Since 2005, Guidea has invested in 70+ startups that now have a combined valuation of $20B. Their partnerships with some of the world’s most innovative companies have earned awards like: The MedTech Breakthrough Award Most Innovative Digital Health Solutions Platform, and Best SaaS-Enabled Digital Health Platform. Learn more at femovate.com.

++ Meet the Companies Selected For Femovate ‘22 ++

BREAST HEALTH

DeepLook Medical

DeepLook Medical is revolutionizing radiology for cancer screening, diagnosis, and treatment, with their FDA-approved, patent-protected software. The shape recognition software accurately measures, segments, and displays the density of soft tumor masses in Mammograms, Ultrasounds, CT scans, and MRI images — with just one click.

Location: United States

CARDIOVASCULAR

Armor Medical Inc

Armor Medical Inc is developing technology to combat postpartum hemorrhage, one of the leading causes of preventable maternal death worldwide.

Location: United States

CHRONIC CONDITIONS

Hashiona

Hashiona offers personalized nutrition plans and symptom tracking for the management of Hashimoto’s disease.

Location: Poland

AIMA Laboratories

AIMA Laboratories is developing an at-home screening test that will shorten the path to diagnosis and treatment for endometriosis.

Location: Canada

Lasa Health

Lasa Health is a digital companion for people with endometriosis, providing care navigation and evidence-based patient education.

Location: United States

DATA & INSIGHTS

Dragonfly Data Ventures

Dragonfly Data Ventures encourages its users to better understand and benefit from their unique data.

Location: United States

FemHealth Insights

FemHealth Insights aims to alter the face of FemTech by providing a comprehensive data platform that encompasses everything there is to know about the FemTech market.

Location: United States

FERTILITY

ELANZA Wellness

ELANZA is a personalized wellness platform, offering resources and support to reduce stress without the use of therapy or medication.

Location: United States

EmGenysis, Inc

EmGenysis employs AI-driven video analysis to determine the viability of an embryo, boosting the likelihood of a successful implantation.

Location: United States

Fertilitæ

Fertilitae increases accessibility to fertility wellness through automated assessments, personalized plans, care, and education on a mobile app.

Location: England

Embie Clinic Ltd

Embie empowers those undergoing IVF and IUI treatments to manage their fertility journey with personalized tracking, insights, and community support.

Location: Israel

Mindful IVF

Mindful IVF leverages extensive fertility expertise and the science of meditation to foster a healthier, happier IVF journey.

Location: Ireland

GENERAL HEALTH

Betty’s Co

Betty’s Co. is the next generation of care for Gen-Z – normalizing, destigmatizing and depoliticizing womxn’s healthcare through integrative gynecology, mental health, and wellness care.

Location: United States

Chava

Chava is the first comprehensive platform providing access to sexual and reproductive health education, community, and care for young women in Latin America.

Location: Nicaragua

Hopstair

HopStair provides confidence coaching via an app to help its users build their core foundation, unlock their full potential, and achieve their goals.

Location: England

HORMONE HEALTH

Eli Health

Eli is the women’s health company providing at-home insights in real-time, and over a lifetime, from hormones in saliva.

Location: Canada

truliWELL

truliWELL is a digital health platform that empowers women of color to be their own best “healthcare providers” through at-home testing, a personalized plan, in-app tracking, and asynchronous coaching — all grounded in functional medicine health coaching principles.

Location: United States

MATERNAL HEALTH

Avira Health

Avira Health develops technology to uplift the mother-infant dyad during the life-changing transition into motherhood and beyond.

Location: United States

EXO Technologies

EXO is battling disparities in women’s health research and treatment while enhancing the standard of care for maternal health.

Location: United States

Momsanity

Momsanity aims to provide support for mothers suffering from Postpartum Depression.

Location: Austria and Bulgaria

MENOPAUSE

Elektra Health

Elektra’s comprehensive digital health platform helps women navigate the 10-year menopause transition. It offers virtual support from a dedicated “Elektra Guide” (i.e., menopause doula), on-demand and evidence-based education built by board-certified doctors, and a private, moderated community.

Location: United States

MENSTRUATION

NuroKor FemTech

NuroKor FemTech is developing bioelectronic wearable solutions for underserved conditions affecting female health on a global scale.

Location: England

Essence

Essence helps women thrive at work and in life by offering evidence-based nutrition and exercise tips, productivity tools, and self-care resources based on the menstrual cycle.

Location: Germany

Salad | Wellness for Women

Salad is creating a lifestyle management platform that works in harmony with a woman’s menstrual cycle.

Location: India

PELVIC FLOOR HEALTH

Cosm Medical

Cosm Medical is developing a digital gynecology platform to create custom-made, gynecological prosthetics for pelvic floor disorders and beyond.

Location: Canada

Elana Health

Elana Health aims to transform the conversation around pelvic care, offering an abundance of resources and educational materials.

Location: United States

Hyivy Health

Hyivy Health provides data-driven medical devices that facilitate the rehabilitation of the pelvic floor.

Location: Canada

REPRODUCTIVE HEALTH

Pera Labs

Pera Labs takes a holistic approach to building healthy tomorrows by providing affordable and efficient fertility solutions for both men and women.

Location: United States

SEXUAL HEALTH

Organa

Organa is dedicated to promoting women’s sexual wellness, harnessing the power of AI to enhance sexual knowledge and pleasure.

Location: Israel

UTERINE HEALTH

Nesa Medtech:

Nesa Medtech pioneers a novel scarless solution to treat uterine fibroids.

Location: India

The Latest Release of Ez1095 2022 ACA Software Offers New 2022 Efile…


The latest edition of 2022 ez1095 software offered for processing Efile Schema For IRS and State Processing. Visit halfpricesoft.com at no cost or obligation to test drive for up to 30 days.

(PRWeb December 01, 2022)

Read the full story at https://www.prweb.com/releases/the_latest_release_of_ez1095_2022_aca_software_offers_new_2022_efile_schema_for_state_and_irs/prweb19020077.htm

National Nutrition Partners with Land Art To Offer 55 New Products


National Nutrition, the leading Canadian provider of vitamins, minerals, nutritional supplements, and other health products, has announced a new partnership with Land Art supplements, a Canadian leader in liquid supplements. The partnership will see 55 new products added to National Nutrition’s product line-up.

High-Quality Liquid Supplements Made in Canada

Land Art’s natural liquid supplements are developed by science. Their team is comprised of biochemists, biologists, chemists, nutritionists, microbiologists, flavour chemists and naturopaths. Land Art is best known for its liquid aloe and chlorophyll supplements. Aloe vera is a nutritious natural dietary supplement that provides, digestive enzymes and polysaccharides. Chlorophyll is a natural liquid supplement that helps to detoxifying the body and promoting the deodorization of the body;

Liquid supplements are easy to dose and act faster as they are easily digested, easily absorbed. Plus, liquid supplements are convenient to take if you don’t like swallowing pills. Land Art offers some vegan, organic, gluten-free supplements products with no sugar added. All of their products are proudly made in Quebec, Canada, at their Ecocert NOP organic-certified facility.

55 New Land Art Supplements Added to National Nutrition’s Offering

This partnership will see 55 new Land Art products added to National Nutrition’s offerings. The new partnership will provide more Canadians with access to high-quality liquid supplements that are effective and great-tasting.

National Nutrition has just added Land Art’s drinkable aloe vera in delicious flavours like cranberry, orange tangerine, pomegranate, and unflavoured. National Nutrition has also just added Chloralfa, an all-natural mouthwash. Chloralfa is made with a combination of chlorophyll, oregano oil, and thyme oil, to deliver long-lasting fresh breath. Chlorophyll is known for its strong deodorizing effects, while oregano oil contains antiviral and antibacterial properties for teeth and gums, and thyme oil fights bad breath by removing plaque and keeps gums healthy.

“We are thrilled to be able to offer our products to National Nutrition’s customers,” says Andréanne Levac, Director Of Marketing at Land Art. “National Nutrition is a leader in this space, and we know that their loyal customers will love our products.”

National Nutrition’s CEO Darren Firth says, “Our customers will love Land Art’s liquid supplements, their quality is second to none.” He continues, “Liquid supplements are a wonderful option for those who don’t like to swallow pills, and we love how clean and efficacious Land Art’s supplements are.”

Land Art products were created for people who seek an alternative to traditional medicine: plant-based supplements that are 100% Canadian made, using only premium ingredients and their products are 3rd party tested. These products are also recommended by naturopathic doctors and holistic nutritionists.

You can shop Land Art’s full range of products on their designated brand page at National Nutrition.ca

About National Nutrition

For over 25 years, National Nutrition dot CA has remained a customer favourite for vitamins and supplements. Their customer-oriented approach and high-quality supplement range from leading brands have led them to be Canada’s trusted name in all things natural health. They even take it one step further and provide educational content for their customers through videos on their Youtube Channel and Supplement articles on their website.

Share article on social media or email:

Mount Sinai Health System Unraveling Cancer’s Complexities


Credit: Icahn School of Medicine at Mount Sinai

“Frontiers of Medical Research: Cancer,” a Science magazine supplement published on November 25 in collaboration with the Icahn School of Medicine at Mount Sinai, explores insights into this complex group of diseases, and strides made in treating them, as reported by researchers from The Tisch Cancer Institute.

The new issue of Frontiers, which debuted in 2021, is the second in the series and probes such topics as:

  • Novel techniques for previously undruggable cancer targets
  • Developments in multiple myeloma
  • Advances in research aimed at preventing recurrence
  • Pioneering approaches in the growing fight against liver cancer
  • Increases in understanding of how cancer evades the immune system and promotes tumor growth


View the current issue at Frontiers of Medical Research: Cancer.

To arrange media interviews with any of the investigators featured, contact newsmedia@mssm.edu.

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 34 academic departments and 35 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.

Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

——————————————————-

  • Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York City and in the top five globally, and Mount Sinai Morningside in the top 30 globally; Newsweek also ranks The Mount Sinai Hospital highly in 11 specialties in “World’s Best Specialized Hospitals,” and in “America’s Best Physical Rehabilitation Centers.”

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Building a World-Class Regulatory Intelligence and Support System Webinar on December 13, 2022


Having a regulatory intelligence management process is crucial if medical device and pharmaceutical manufacturers want to keep up with relevant changes. It will ensure they’re streamlining compliance with regulatory modifications throughout their organization, preparing for new and amended regulations impacting distribution.

Two regulatory intelligence professionals from Edwards Lifesciences will explain how to institute a regulatory intelligence system. Dennett Kouri, senior vice president, and Faviola Michelot, senior director, will detail how to build a regulatory intelligence management system that will enable attendees to stay ahead of the changes and stay compliant.

Webinar Takeaways:


  • What regulatory intelligence is and how to develop and implement it
  • What resources are needed to support regulatory intelligence
  • The new regulatory trends manufacturers must have on their radar
  • How to pursue engaging opportunities with regulators
  • How to determine staff qualifications for optimal efficiency

Webinar Details

Building a World-Class Regulatory Intelligence and Support System:

What Regulatory, Compliance and Quality Professionals Need to Know

An FDAnews Webinar

Tuesday, December 13, 2022, 1:30 p.m. – 3:00 p.m. EST

https://wcg.swoogo.com/building-a-world-class-regulatory-intelligence

Price:

$287

Easy Ways to Order:

Online: https://wcg.swoogo.com/building-a-world-class-regulatory-intelligence

By phone: 888.838.5578 or 703.538.7600

About WCG FDAnews:

WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews’ newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations. Learn more at fdanews.com.

Share article on social media or email: